Early detection is one of the most effective ways to improve skin cancer outcomes, but access to regular and comprehensive skin screenings remains limited for many people. Los Angeles-based health technology startup SkinBit aims to change that with its AI-powered full-body skin scanning platform. The company has now raised $6 million in pre-seed funding to support the next stage of its growth and bring its technology to more healthcare settings.
The investment will help SkinBit expand its presence and continue building a platform designed to improve early skin cancer detection through advanced imaging and artificial intelligence.
SkinBit Announces $6 Million Pre-Seed Round
SkinBit has secured $6 million in pre-seed funding from a group of investors that includes Boost VC, Cleo Capital, Manna Ventures, Profluent Capital, Lyft co-founder Logan Green, and nine board-certified dermatologists.
Founded in 2023 by Jonathan Benassaya, SkinBit is headquartered in Los Angeles, California. The company is focused on developing technology that enables fast, full-body skin scans while creating a longitudinal skin health data platform. The goal is to help identify changes in the skin over time and support earlier detection of skin cancer.
Building a New Approach to Skin Health
SkinBit’s platform combines proprietary scanning hardware with artificial intelligence to capture detailed full-body skin images. Rather than relying on a single examination, the company is building a longitudinal database that tracks skin health over time.
By comparing images collected during multiple visits, the platform is designed to help detect new or changing skin lesions that may require further evaluation by a healthcare professional. This approach aims to support dermatologists and improve access to routine skin monitoring.
The company believes that continuous monitoring can play an important role in identifying skin abnormalities at an earlier stage, when treatment is often more effective.
Expansion Plans Following the Funding
SkinBit plans to deploy its full-body skin scanners in medical spas, longevity clinics, and dermatology practices. These locations will provide patients with easier access to comprehensive skin scans without requiring specialized imaging equipment in every clinic.
According to the company, it expects to have three operating locations during 2026 and plans to expand to 15 locations by the end of 2027. This rollout marks the first phase of SkinBit’s commercial expansion strategy. The funding provides the company with the resources needed to execute these deployment plans while continuing to develop its skin health platform.
Supporting Earlier Skin Cancer Detection
Skin cancer remains one of the most commonly diagnosed cancers, making early detection an important part of preventive healthcare. SkinBit is developing its technology to help healthcare providers monitor patients more effectively by creating consistent visual records of skin health.
Instead of replacing medical professionals, the platform is intended to provide additional information that can assist clinical decision-making and encourage timely follow-up when changes are detected. The participation of experienced healthcare professionals, including nine board-certified dermatologists, reflects growing interest in technologies that can strengthen preventive skin care.
Looking Ahead
With its new $6 million pre-seed funding, SkinBit is preparing to bring its AI-powered full-body skin scanning platform to more healthcare providers across the United States. As the company expands into medical spas, longevity clinics, and dermatology practices, it aims to make regular skin monitoring more accessible while building one of the largest longitudinal skin health data platforms.
The latest funding marks an important milestone for the startup as it works toward improving early skin cancer detection through technology and data-driven healthcare.
